LBA21InterAACT: A multicentre open label randomised phase...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

LBA21InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial

Rao, S, Sclafani, F, Eng, C, Grønlie Guren, M, Adams, R A, Benson, A, Sebag-Montefiore, D, Segelov, E, Bryant, A, Peckitt, C, Roy, A, Seymour, M T, Welch, J, Saunders, M P, Muirhead, R, Bridgewater, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy424.022
Date:
October, 2018
File:
PDF, 96 KB
english, 2018
Conversion to is in progress
Conversion to is failed